Literature DB >> 21631694

Increased incidence of Leydig cell tumours of the testis in the era of improved imaging techniques.

Nicolai Leonhartsberger1, Reinhold Ramoner, Friedrich Aigner, Brigitte Stoehr, Renate Pichler, Florian Zangerl, Andreas Fritzer, Hannes Steiner.   

Abstract

OBJECTIVE: To report an observed high frequency of Leydig cell tumours (LCTs) diagnosed at our centre. PATIENTS AND METHODS: Charts of all patients who underwent surgery for a testicular tumour between 1999 and 2008 at our department were searched and data from patients with LCT were collected. Before surgery all patients underwent ultrasound and complete staging. In all but two patients with LCT an organ-sparing surgery was performed. Surgery was performed under ultrasound or palpation guidance. All patients underwent postoperative follow-up. We retrospectively reviewed surgical technique, histology, epidemiology and outcome in all LCT patients.
RESULTS: In the study period, 197 testicular tumours were surgically removed of which 29 were diagnosed as LCT (14.7% of 197; further study group) in 25 patients. Mean age of patients with LCT was 45 years (range 21-68 years). Tumour size ranged from 1.2 to 80 mm (mean 10.23 mm). In two patients (8%) the lesion was palpable whereas incidental diagnosis was made in seven patients (28%). In the remaining patients diagnosis was made by ultrasound performed for testicular pain (six patients, 24%) or during infertility or erectile dysfunction evaluation (10 patients, 40%). Definitive histology reported no malignant histopathological features in all but one patient; this particular patient experienced tumour progression after 2 months and died from advanced disease 1 year later. All other patients are free of disease after a mean follow up of 56 months (range 7-93 months). During this period one patient developed a second LCT on the contralateral side; another patient had a recurrence within the same testicle, but on the opposite pole. Both underwent a subsequent organ-sparing tumour resection.
CONCLUSION: The percentage of LCT (14.7% of all testicular tumours removed) was significantly higher than expected from the literature. One possible explanation for this phenomenon is the increasing use of better ultrasound technology and the subsequent increased detection of small nodules that have not been found in historical series. Use of 'observation-only' for very small lesions detected at infertility clinics is under debate.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631694     DOI: 10.1111/j.1464-410X.2011.10177.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  One lump or two? Concomitant Leydig cell tumour and paratesticular leiomyoma in an adult man.

Authors:  Diwei Lin; Amanda Jia Hui Tan; Theresa Power; Rajinder Singh-Rai
Journal:  BMJ Case Rep       Date:  2014-05-21

Review 2.  Multiparametric ultrasonography of the testicles.

Authors:  Tobias De Zordo; Daniel Stronegger; Leo Pallwein-Prettner; Chris J Harvey; Germar Pinggera; Werner Jaschke; Friedrich Aigner; Ferdinand Frauscher
Journal:  Nat Rev Urol       Date:  2013-01-22       Impact factor: 14.432

3.  FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.

Authors:  Ming-Min Chang; Meng-Shao Lai; Siou-Ying Hong; Bo-Syong Pan; Hsin Huang; Shang-Hsun Yang; Chia-Ching Wu; H Sunny Sun; Jih-Ing Chuang; Chia-Yih Wang; Bu-Miin Huang
Journal:  Cancer Sci       Date:  2018-10-23       Impact factor: 6.716

4.  Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study.

Authors:  Florian Laclergerie; Guillaume Mouillet; Alexandre Frontczak; Loïc Balssa; Pascal Eschwege; Christian Saussine; Stéphane Larré; Luc Cormier; Antoine Thiery Vuillemin; François Kleinclauss
Journal:  World J Urol       Date:  2017-12-11       Impact factor: 4.226

5.  Microscopic testicular sperm extraction or post-operative sperm reversal in functional Leydig cell tumor: case report.

Authors:  Zhongyan Liang; Zhanwang He; Chong Chen; Fengbin Zhang; Jingping Li; Jinggen Wu
Journal:  Transl Androl Urol       Date:  2019-10

6.  Organ-sparing surgery is the treatment of choice in benign testicular tumors.

Authors:  Nicolai Leonhartsberger; Renate Pichler; Brigitte Stoehr; Wolfgang Horninger; Hannes Steiner
Journal:  World J Urol       Date:  2013-10-04       Impact factor: 4.226

7.  A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome.

Authors:  Lindsay M Yuh; Primo N Lara; Rebecca M Wagenaar; Christopher P Evans; Marc A Dall'era; Rosemary Cress; Stanley A Yap
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

8.  Colour Doppler and ultrasound characteristics of testicular Leydig cell tumours.

Authors:  Florian Maxwell; Vincent Izard; Sophie Ferlicot; Antoine Rachas; Jean-Michel Correas; Gérard Benoit; Marie-France Bellin; Laurence Rocher
Journal:  Br J Radiol       Date:  2016-04-13       Impact factor: 3.039

9.  Leydig cell tumors of the testis: a case report.

Authors:  Ancuta Augustina Gheorghisan-Galateanu
Journal:  BMC Res Notes       Date:  2014-09-18

10.  Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess.

Authors:  Vasileios Chortis; Nicholas J Johal; Irina Bancos; Matthew Evans; Kassiani Skordilis; Peter Guest; Michael H Cullen; Emilio Porfiri; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.